In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines

Peptides

Volumn 24, Issue 7, 2003, Pages 945-953

  Kim, Sunkyu ^a   Kim, Sukwon S ^a   Bang, Yung Jue ^a   Kim, Seong Jin ^b   Lee, Byeong Jae ^a  

^a Seoul National University   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antimicrobial peptide; Antitumor activity; Derivative; Gaegurin 6; MCF 7 DOX; MDR

Indexed keywords

DNA FRAGMENT; POLYPEPTIDE ANTIBIOTIC AGENT;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HYDROPHOBICITY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TUMOR CELL LINE;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0141741478     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(03)00194-3     Document Type: Article

References (29)

1. Alley M.C., Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S.et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:1988;4827-4833.
2. Ambudkar S.V., Dey S., Christine H., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxocol. 39:1999;361-398.
3. Barra D., Simmaco D. Amphibian skin: a promising resource for antimicrobial peptides. Trends Biotechnol. 13:1995;205-209.
4. Benchimol S., Ling V. P-glycoprotein and tumor progression. J. Natl. Cancer Inst. 86:1994;814-816.
5. Biedler J.L., Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross resistance, radioautographic and cytogenetic studies. Cancer Res. 30:1970;1174-1184.
6. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immun. 13:1995;61-92.
7. Chen Y., Xu C., Hong S., Chen J., Liu N., Underhill C.B.et al. RGD-tachyplesin inhibits tumor growth. Cancer Res. 61:2001;2434-2438.
8. Cruciani R.A., Barker J.L., Zasloff M., Chen H.C., Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3792-3796.
9. Dathe M., Kaduk C., Tachikawa E., Melzig M.F., Wenschuh H., Bienert M. Proline at position 14 of alamethicin is essential for hemolytic activity, catecholamine secretion from chromaffin cells and enhanced metabolic activity in endothelial cells. Biochim. Biophys. Acta. 1370:1998;175-183.
10. Eisenberg D., Schwarz E., Komaromy M., Wall R. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 179:1984;125-142.
11. Ellerby H.M., Arap W., Ellerby L.M., Kain R., Andrusiak R., Rio G.D.et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med. 5:1999;1032-1038.
12. Gabay J.E. Ubiquitous natural antibiotics. Science. 264:1994;373-374.
13. Giangaspero A., Sandri L., Tossi A. Amphipathic α-helical antimicrobial peptides. Eur. J. Biochem. 268:2001;5589-5600.
14. Hoffmann J.A. Innate immunity of insects. Curr. Opin. Immunol. 7:1995;4-10.
15. Jaynes J.M., Julian J.R., Jeffers G.W., White K.L., Enright F.M. In vitro cytocidal effect of lytic peptides on several transformed mammalian cell lines. Pept. Res. 2:1989;157-160.
16. Johnstone S.A., Gelmon K., Mayer L.D., Hancock R.E., Bally M.B. In vitro characterizationof the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and P-glycoprotein over-expressing tumor cell lines. Anti-Cancer Drug Design. 15:2001;151-160.
17. Kim S., Kim J.Y., Lee B.J., Kim S.J. Synthesis and characterization of GGN4 and its tryptophan substituted analogue peptides. J. Biochem. Mol. Biol. 32:1999;12-19.
18. Lee K.H., Hong S.Y., Oh J.E., Lee B.J., Choi B.S. Antimicrobial activity and conformation of gaegurin-6 amide and its analogs. Peptides. 19:1998;1653-1658.
19. Mai J.C., Mi Z., Kim S.-H., Ng B., Robbins P.D. A proapoptotic peptide for the treatment of solid tumor. Cancer Res. 61:2001;7709-7712.
20. Merrifield B. Solid phase synthesis. Science. 232:1986;341-347.
21. Nicolas P., Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 49:1995;277-304.
22. Ohsaki Y., Gazdar A.F., Chen H.C., Johnson B.E. Antitumor activity of magainin analogues against human lung cancer cell lines. Cancer Res. 2:1992;3534-3538.
23. Oren Z., Hong J., Shai Y. A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J Biol. Chem. 272:1997;14643-14649.
24. Park J.M., Jung J.E., Lee B.J. Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. Biochem. Biophys. Res. Commun. 205:1994;948-954.
25. Risso A., Braidot E., Sordano M.C., Vianello A., Macri F., Skerlavaj B. et al. BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol. Cell Biol. 22:2002;1926-1935.
26. Sharom F.J., DiDiodato G., Yu X., Ashbourne K.J.D. Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores. J. Biol. Chem. 270:1995;10334-10341.
27. Shi Y.F., Sahai B.M., Green D.R. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature. 339:1989;625-626.
28. Simmaco M., Mignogna G., Canofeni S., Mangoni M.L., Barra D. Temporins, antimicrobial peptides from the European red frog, Rana temporaria. Eur. J. Biochem. 242:1996;788-792.
29. Tosteson M.T., Holmes S.J., Razin M., Tosteson D.C. Melittin lysis of red cells. J. Membr. Biol. 87:1985;35-44.